Keyphrases
Attenuation
100%
Intracerebral Hemorrhage
100%
Edema
100%
Non-traumatic
100%
Clinical Protocols
100%
Neuroinflammation
66%
Functional Outcome
50%
Cerebral Edema
50%
All-cause Mortality
33%
Symptom Onset
33%
Spontaneous Intracerebral Hemorrhage
33%
Tolerability
16%
Placebo
16%
Cerebrospinal Fluid
16%
Adverse Events
16%
Randomized Placebo-controlled Trial
16%
Inflammatory Cytokines
16%
Clinical Trials
16%
Large Trials
16%
Pharmacokinetics
16%
Healthy Adults
16%
Death Rate
16%
Hospital Discharge
16%
Vital Signs
16%
Non-inferiority
16%
Perihematomal Edema Volume
16%
Drug Candidates
16%
Central Nervous System Injury
16%
Phase 1 Study
16%
Neurologic Complications
16%
Acute Brain Injury
16%
Plasma Fluid
16%
Small Molecule Drugs
16%
Cytokine Concentration
16%
Post-randomization
16%
Conceptual Phase
16%
Tolerance Limits
16%
First-in-patient
16%
Medicine and Dentistry
Biological Marker
100%
Clinical Trial
100%
Cerebral Hemorrhage
100%
Edema
100%
Neuroinflammation
50%
Brain Edema
37%
All Cause Mortality
25%
Symptom
25%
Placebo
25%
Arm
25%
Central Nervous System
12%
Cerebrospinal Fluid
12%
Adverse Event
12%
Inflammatory Cytokine
12%
Brain Injury
12%
Sodium Chloride
12%
Neurological Complication
12%
Nervous System Injury
12%
Pharmacokinetics
12%
Vital Sign
12%
Safety Case
12%
Pharmacology, Toxicology and Pharmaceutical Science
Clinical Trial
100%
Biological Marker
100%
Brain Hemorrhage
100%
Edema
100%
Nervous System Inflammation
50%
Brain Edema
37%
Placebo
25%
Symptom
25%
All Cause Mortality
25%
Adverse Event
12%
Tolerability
12%
Cytokine
12%
Normal Human
12%
Pharmacokinetics
12%
Preclinical Study
12%
Sodium Chloride
12%
Brain Injury
12%
Nervous System Injury
12%
Neurological Complication
12%
Safety Case
12%